• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Am-Pharma B.V. - Product Pipeline Review - Q1 2011 Product Image

Am-Pharma B.V. - Product Pipeline Review - Q1 2011

  • ID: 1590045
  • March 2011
  • 32 pages
  • Global Markets Direct

Am-Pharma B.V. – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Am-Pharma B.V. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Am-Pharma B.V. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Am-Pharma B.V. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the READ MORE >



List of Tables
List of Figures
Am-Pharma B.V. Snapshot
Am-Pharma B.V. Overview
Key Information
Key Facts
Am-Pharma B.V. – Research and Development Overview
Key Therapeutic Areas
Am-Pharma B.V. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Am-Pharma B.V. – Pipeline Products Glance
Am-Pharma B.V. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Am-Pharma B.V.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Am-Pharma B.V. – Drug Profiles
Bovine Alkaline Phosphatase
Product Description
Mechanism of Action
R&D Progress
Bovine Intestinal Alkaline Phosphatase
Product Description
Mechanism of Action
R&D Progress
hLF1-11
Product Description
Mechanism of Action
R&D Progress
Recombinant Alkaline Phosphatase
Product Description
Mechanism of Action
R&D Progress
Am-Pharma B.V. – Pipeline Analysis
Am-Pharma B.V. – Pipeline Products by Therapeutic Class
Am-Pharma B.V. - Pipeline Products By Target
Am-Pharma B.V. – Pipeline Products by Route of Administration
Am-Pharma B.V. – Pipeline Products by Molecule Type
Am-Pharma B.V. – Locations And Subsidiaries
Head Office
Recent Developments
Mar 10, 2010: AM-Pharma Presents Positive Results of Its Phase II Clinical Trial With Alkaline Phosphatase in Acute Kidney Injury At The ISICEM Conference In Brussels
Jul 09, 2008: AM-Pharma Announces Start Of second Phase II trial In Acute Renal Failure
Jul 09, 2008: AM-Pharma Announces Start Of Second Phase II Trial In Acute Renal Failure
Dec 03, 2007: AM-Pharma Announces Positive Results Of A Phase IIa Clinical Trial With Alkaline Phosphatase In Acute Renal Failure
Jul 09, 2007: AM-Pharma announces positive results of Phase IIa clinical trial with Alkaline Phosphatase for ulcerative colitis
Jul 09, 2007: AM-Pharma Announces Positive Results Of Phase IIa Clinical Trial With Alkaline Phosphatase For Ulcerative Colitis
Financial Deals Landscape
Am-Pharma B.V., Deals Summary, 2004 to 2011
Am-Pharma B.V. Detailed Deal Summary
Venture Financing
AM-Pharma Completes First Close Of $11.03 Million In Series C Financing Round
AM-Pharma Secures $3.42 Million In Venture Financing
AM-Pharma Secures $10.86 Million In Series B Financing Round
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Am-Pharma B.V. – Pipeline by Therapy Area and Indication, 2011
Am-Pharma B.V. – Pipeline by Stage of Development, 2011
Am-Pharma B.V. – Monotherapy Products in Pipeline, 2011
Am-Pharma B.V. - Phase II, 2011
Am-Pharma B.V. - Pipeline By Therapeutic Class, 2011
Am-Pharma B.V. - Pipeline By Target, 2011
Am-Pharma B.V. – Pipeline By Route of Administration, 2011
Am-Pharma B.V. – Pipeline By Molecule Type, 2011
Am-Pharma B.V., Deals Summary, 2004 to 2011

List of Figures
Am-Pharma B.V. – Pipeline by Therapy Area and Indication, 2011
Am-Pharma B.V. – Pipeline by Stage of Development, 2011
Am-Pharma B.V. – Monotherapy Products in Pipeline, 2011
Am-Pharma B.V. – Pipeline By Therapeutic Class, 2011
Am-Pharma B.V. - Pipeline By Target, 2011
Am-Pharma B.V. – Pipeline By Route of Administration, 2011
Am-Pharma B.V. – Pipeline By Molecule Type, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos